Jaidyn Muhandiramge1,2, John R Zalcberg3,4, G J van Londen5, Erica T Warner6, Prudence R Carr3, Andrew Haydon4, Suzanne G Orchard3. 1. Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC, 3004, Australia. jaidyn.muhandiramge@monash.edu. 2. Austin Health, Heidelberg, VIC, Australia. jaidyn.muhandiramge@monash.edu. 3. Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC, 3004, Australia. 4. Department of Medical Oncology, Alfred Hospital, Melbourne, VIC, Australia. 5. Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. 6. Clinical and Translational Epidemiology Unit, MGH Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Abstract
PURPOSE OF REVIEW: Cardiovascular disease is long-term complication of both cancer and anti-cancer treatment and can have significant ramifications for health-related quality of life and mortality. This narrative review explores the current evidence linking cardiovascular disease and cancer, as well as exploring strategies for the prevention and management of cardiovascular disease, and outlines future opportunities in the field of cardio-oncology. RECENT FINDINGS: Cancer confers risk for various cardiovascular diseases including heart failure, cardiomyopathy, arrhythmia, coronary heart disease, stroke, venous thromboembolism, and valvular heart disease. Cancer treatment, in particular agents such as platinum-based chemotherapy, anthracyclines, hormonal treatments, and thoracic radiotherapy, further increases risk. While cardiovascular disease can be identified early and effectively managed in cancer survivors, cardiovascular screening and management does not typically feature in routine long-term cancer care of adult cancer survivors. Cancer and cancer treatment can accelerate the development of cardiovascular disease. Further research into screening and management strategies for cardiovascular disease, along with evidence-based guidelines, is required to ensure adult cancer survivors receive appropriate long-term care.
PURPOSE OF REVIEW: Cardiovascular disease is long-term complication of both cancer and anti-cancer treatment and can have significant ramifications for health-related quality of life and mortality. This narrative review explores the current evidence linking cardiovascular disease and cancer, as well as exploring strategies for the prevention and management of cardiovascular disease, and outlines future opportunities in the field of cardio-oncology. RECENT FINDINGS: Cancer confers risk for various cardiovascular diseases including heart failure, cardiomyopathy, arrhythmia, coronary heart disease, stroke, venous thromboembolism, and valvular heart disease. Cancer treatment, in particular agents such as platinum-based chemotherapy, anthracyclines, hormonal treatments, and thoracic radiotherapy, further increases risk. While cardiovascular disease can be identified early and effectively managed in cancer survivors, cardiovascular screening and management does not typically feature in routine long-term cancer care of adult cancer survivors. Cancer and cancer treatment can accelerate the development of cardiovascular disease. Further research into screening and management strategies for cardiovascular disease, along with evidence-based guidelines, is required to ensure adult cancer survivors receive appropriate long-term care.
Authors: Mélanie Demers; Daniela S Krause; Daphne Schatzberg; Kimberly Martinod; Jaymie R Voorhees; Tobias A Fuchs; David T Scadden; Denisa D Wagner Journal: Proc Natl Acad Sci U S A Date: 2012-07-23 Impact factor: 11.205
Authors: Jennifer L Guida; Tanya Agurs-Collins; Tim A Ahles; Judith Campisi; William Dale; Wendy Demark-Wahnefried; Jorg Dietrich; Rebecca Fuldner; Lisa Gallicchio; Paige A Green; Arti Hurria; Michelle C Janelsins; Chamelli Jhappan; James L Kirkland; Ronald Kohanski; Valter Longo; Simin Meydani; Supriya Mohile; Laura J Niedernhofer; Christian Nelson; Frank Perna; Keri Schadler; Jessica M Scott; Jennifer A Schrack; Russell P Tracy; Jan van Deursen; Kirsten K Ness Journal: J Natl Cancer Inst Date: 2021-02-01 Impact factor: 13.506
Authors: Dounya Schoormans; Pauline A J Vissers; Myrthe P P van Herk-Sukel; Johan Denollet; Susanne S Pedersen; Susanne O Dalton; Nina Rottmann; Lonneke van de Poll-Franse Journal: Cancer Med Date: 2018-09-15 Impact factor: 4.452